Uncategorized
VIDEO: Real-world Xen glaucoma implant technique improves on FDA-approved technique
BALTIMORE ― At the Association for Research in Vision and Ophthalmology meeting here, Davinder S. Grover, MD, MPH, discusses an FDA-approved, prospective, open-label study of the Allergan Xen implant for the treatment of refractory glaucoma. The study looks at a less-invasive "real-world" ab interno technique than the one approved in the FDA clinical trial.